The U.S. The Commerce Department will soon allow Nvidia Corp's H200 chip to be exported to China, Semafor news outlet reported on Monday, citing a person with knowledge of the plan (source: Reuters).
The gains in the Nvidia (NVDA.US) accelerated after the report was passed through reuters. The stock is currently up 3% despite minor early trading losses.
The news comes only three days after a proposition of a bipartisan U.S. Senate bill, the Secure and Feasible Exports Chips Act, which would block Nvidia from selling its most advanced AI chips (H200 and Blackwell) to China for 30 months, aiming to limit Beijing’s access to frontier AI technology.
Source: xStation5
Morning Wrap (10.12.2025)
Paramount Throws Down the Gauntlet to Netflix in the Battle for Warner Bros Discovery!
US Open: US100 loses 0.3% in pre-market ๐ฝNvidia gains amid Trump decision on AI chip export to China
DE40: Record German Defense Spending Boosts Markets๐
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
